A new clinical trial presented at the 2024 American Society for Nutrition Annual Meeting evaluated the effects of 100 milligrams of Boswellia serrata

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today

Kenox Pharmaceuticals Inc (Kenox), a fast-growing company dedicated to developing innovative Orally Inhaled and Nasal Drug Products.

Dr. Huiming Li, Deputy General Manager of Kexing Biopharm New Drug Research Center, Biotech

Traws Pharma, Inc. a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment

Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology

AllSci has opened its Development Partner Program to R&D-driven life science organizations seeking to leverage the power of its revolutionary AI platform.

Systech, part of Markem-Imaje and Dover and a leading provider of digital identification and traceability software solutions, today announced the introduction

Stuart Therapeutics, Inc. a clinical-stage drug platform company developing novel therapies for ophthalmic diseases, today announced last patient

YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial